Authors:
Natchus, MG
Bookland, RG
Laufersweiler, MJ
Pikul, S
Almstead, NG
De, B
Janusz, MJ
Hsieh, LC
Gu, F
Pokross, ME
Patel, VS
Garver, SM
Peng, SX
Branch, TM
King, SL
Baker, TR
Foltz, DJ
Mieling, GE
Citation: Mg. Natchus et al., Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines, J MED CHEM, 44(7), 2001, pp. 1060-1071
Authors:
Soper, DL
Milbank, JBJ
Mieling, GE
Dirr, MJ
Kende, AS
Cooper, R
Jee, WSS
Yao, W
Chen, JL
Bodman, M
Lundy, MW
De, B
Stella, ME
Ebetino, FH
Wang, YL
deLong, MA
Wos, JA
Citation: Dl. Soper et al., Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis, J MED CHEM, 44(24), 2001, pp. 4157-4169
Authors:
Soper, DL
Milbank, JBJ
Mieling, GE
Dirr, MJ
Kende, AS
Chen, R
Bodman, M
Lundy, MW
De, B
Stella, ME
Ebetino, FH
Wang, YL
deLong, MA
Wos, JA
Citation: Dl. Soper et al., Synthesis and biological evaluation of prostaglandin-F alkylphosphinic acid derivatives as bone anabolic agents for the treatment of osteoporosis. (vol 44, pg 4157, 2001), J MED CHEM, 44(24), 2001, pp. 4307-4307
Authors:
Pikul, S
Ohler, NE
Ciszewski, G
Laufersweiler, MC
Almstead, NG
De, B
Natchus, MG
Hsieh, LC
Janusz, MJ
Peng, SX
Branch, TM
King, SL
Taiwo, YO
Mieling, GE
Citation: S. Pikul et al., Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases, J MED CHEM, 44(16), 2001, pp. 2499-2502
Authors:
Wang, YL
Wos, JA
Dirr, MJ
Soper, DL
deLong, MA
Mieling, GE
De, B
Amburgey, JS
Suchanek, EG
Taylor, CJ
Citation: Yl. Wang et al., Design and synthesis of 13,14-dihydro prostaglandin F-1 alpha analogues aspotent and selective ligands for the human FP receptor, J MED CHEM, 43(5), 2000, pp. 945-952
Authors:
Cheng, MY
De, B
Pikul, S
Almstead, NG
Natchus, MG
Anastasio, MV
McPhail, SJ
Snider, CE
Taiwo, YO
Chen, LY
Dunaway, CM
Gu, F
Dowty, ME
Mieling, GE
Janusz, MJ
Wang-Weigand, S
Citation: My. Cheng et al., Design and synthesis of piperazine-based matrix metalloproteinase inhibitors, J MED CHEM, 43(3), 2000, pp. 369-380
Authors:
Natchus, MG
Bookland, RG
De, B
Almstead, NG
Pikul, S
Janusz, MJ
Heitmeyer, SA
Hookfin, EB
Hsieh, LC
Dowty, ME
Dietsch, CR
Patel, VS
Garver, SM
Gu, F
Pokross, ME
Mieling, GE
Baker, TR
Foltz, DJ
Peng, SX
Bornes, DM
Strojnowski, MJ
Taiwo, YO
Citation: Mg. Natchus et al., Development of new hydroxamate matrix metalloproteinase inhibitors derivedfrom functionalized 4-aminoprolines, J MED CHEM, 43(26), 2000, pp. 4948-4963
Authors:
Almstead, NG
Bradley, RS
Pikul, S
De, B
Natchus, MG
Taiwo, YO
Gu, F
Williams, LE
Hynd, BA
Janusz, MJ
Dunaway, CM
Mieling, GE
Citation: Ng. Almstead et al., Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors, J MED CHEM, 42(22), 1999, pp. 4547-4562
Authors:
Pikul, S
Dunham, KLM
Almstead, NG
De, B
Natchus, MG
Anastasio, MV
McPhail, SJ
Snider, CE
Taiwo, YO
Chen, LY
Dunaway, CM
Gu, F
Mieling, GE
Citation: S. Pikul et al., Design and synthesis of phosphinamide-based hydroxamic acids as inhibitorsof matrix metalloproteinases, J MED CHEM, 42(1), 1999, pp. 87-94